Expertise in
6
conditions

Dr. William Muller

Infectious Disease
Ann & Robert H. Lurie Children's Hospital Of Chicago
225 E Chicago Ave, 
Chicago, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
Ann & Robert H. Lurie Children's Hospital Of Chicago
225 E Chicago Ave, 
Chicago, IL 

Overview

William Muller is an Infectious Disease provider practicing medicine in Chicago, Illinois.

Dr. Muller is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Neonatal Herpes, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Herpes Simplex Encephalitis.

He is actively involved in clinical research, co-authoring 261 peer reviewed articles and participating in 7 clinical trials.

Specialties

Infectious Disease

Licenses

Pediatric Infectious Diseases in IL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Ann & Robert H. Lurie Children's Hospital of Chicago
225 E Chicago Ave, Chicago, IL 60611

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Enrollment Status: Recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
An Open Label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of a Single Dose Infusion of VABOMERE (Meropenem-Vaborbactam) in Pediatric Subjects From Birth to Less Than 18 Years of Age With Serious Bacterial Infections
An Open Label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of a Single Dose Infusion of VABOMERE (Meropenem-Vaborbactam) in Pediatric Subjects From Birth to Less Than 18 Years of Age With Serious Bacterial Infections
Enrollment Status: Active_not_recruiting
Publish Date: June 04, 2026
Intervention Type: Drug
Study Phase: Phase 1
Assessment of CMV-specific T Cell Responses by Flow Cytometry With Intracellular Cytokine Staining to Predict CMV Infection Risk in Pediatric Solid Organ Transplant Recipients
Assessment of CMV-specific T Cell Responses by Flow Cytometry With Intracellular Cytokine Staining to Predict CMV Infection Risk in Pediatric Solid Organ Transplant Recipients
Enrollment Status: Completed
Publish Date: March 27, 2026
Intervention Type: Other
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Enrollment Status: Completed
Publish Date: September 06, 2023
Intervention Type: Drug
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Enrollment Status: No_longer_available
Publish Date: March 14, 2022
Intervention Type: Drug
View 6 Less Clinical Trials

261 Total Publications

Effectiveness of agricultural interventions to minimise the health impacts of air pollution: a synopsis from a mixed method study.
Effectiveness of agricultural interventions to minimise the health impacts of air pollution: a synopsis from a mixed method study.
Journal: Public health research (Southampton, England)
Published: June 01, 2026
Similar Doctors
Expertise in
8
conditions
Dr. Valentina Stosor
Infectious Disease
Expertise in
8
conditions
Dr. Valentina Stosor
Infectious Disease
Referral may be required
676 N St Clair St Ste 940, Arkes Pavilion, 
Chicago, IL 
 (0.4 miles away)
312-926-8358
Experience:
34+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Valentina Stosor is an Infectious Disease provider practicing medicine in Chicago, Illinois. She has been practicing medicine for over 34 years. Dr. Stosor is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Cytomegalovirus Infection, AIDS Dementia Complex, and Cytomegalic Inclusion Disease. Dr. Stosor is board certified in American Board Of Internal Medicine - Infectious Disease (Certified).

Expertise in
8
conditions
Dr. Audrey French
Infectious Disease
Expertise in
8
conditions
Dr. Audrey French
Infectious Disease
Referral may be required

Office

1900 W Polk St Rm 1243, 
Chicago, IL 
 (3.6 miles away)
312-864-4578
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Audrey French is an Infectious Disease provider practicing medicine in Chicago, Illinois. Dr. French is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Hepatitis C, Hepatitis, and Vitamin D Deficiency.

Expertise in
3
conditions
Dr. Alan Hauser
Infectious Disease
Expertise in
3
conditions
Dr. Alan Hauser
Infectious Disease
Referral may be required

Office

303 E Chicago Ave, 
Chicago, IL 
 (0.1 miles away)
312-695-5085
Languages Spoken:
English

Alan Hauser is an Infectious Disease provider practicing medicine in Chicago, Illinois. Dr. Hauser is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pseudomonas Stutzeri Infections, Hospital-Acquired Pneumonia, Pneumonia, and Sepsis.

Frequently Asked Questions about Dr. William Muller

How do I make an appointment with Dr. William Muller?

You can book an appointment with Dr. William Muller by calling their office at 312-227-4080. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. William Muller a top-rated expert for Neonatal Herpes?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. William Muller is classified as an Distinguished expert for Neonatal Herpes, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. William Muller specialize in?

While Dr. William Muller is a Infectious Disease, they have specific expertise in Neonatal Herpes, Severe Acute Respiratory Syndrome (SARS), and COVID-19. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. William Muller participate in research or clinical trials?

Yes. Dr. William Muller has published 261 articles and abstracts on conditions like Neonatal Herpes. You can view a list of Dr. William Muller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. William Muller accept my insurance?

Dr. William Muller accepts most major insurance plans, including Aetna and Humana. We recommend calling the office directly at 312-227-4080 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Muller's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile